|
|
Geron Corporation
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: P3 clinical data showed durable, continuous transfusion independence with imetelstatPerhaps there is consolidation here especially since GERN is TECHNICALLY showing a very overbought RSI >> 70. Further gains against these headwinds are possible but additional news and institutional buying should help push through to $4 and beyond this month. |
||||||||||||
|
|
return to message board, top of board |
